Safety of Single Intravenous Administration of S95010 in Human Healthy Volunteers
Status:
Completed
Trial end date:
2019-04-10
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess, the safety and tolerability of single ascending doses
of S 95010 and to assess the pharmacokinetics (PK) of S 95010.